Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Veerle Bossuyt"'
Autor:
Siang-Boon Koh, Brian N. Dontchos, Veerle Bossuyt, Christine Edmonds, Simona Cristea, Nsan Melkonjan, Lindsey Mortensen, Annie Ma, Kassidy Beyerlin, Elyssa Denault, Elizabeth Niehoff, Taghreed Hirz, David B. Sykes, Franziska Michor, Michelle Specht, Constance Lehman, Leif W. Ellisen, Laura M. Spring
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract Systematic collection of fresh tissues for research at the time of diagnostic image-guided breast biopsy has the potential to fuel a wide variety of innovative studies. Here we report the initial experience, including safety, feasibility, an
Externí odkaz:
https://doaj.org/article/bb4e9fd066134280a9174b2fe59dc262
Autor:
Erin W. Hofstatter, Steve Horvath, Disha Dalela, Piyush Gupta, Anees B. Chagpar, Vikram B. Wali, Veerle Bossuyt, Anna Maria Storniolo, Christos Hatzis, Gauri Patwardhan, Marie-Kristin Von Wahlde, Meghan Butler, Lianne Epstein, Karen Stavris, Tracy Sturrock, Alexander Au, Stephanie Kwei, Lajos Pusztai
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-11 (2018)
Abstract Background Age is one of the most important risk factors for developing breast cancer. However, age-related changes in normal breast tissue that potentially lead to breast cancer are incompletely understood. Quantifying tissue-level DNA meth
Externí odkaz:
https://doaj.org/article/450421c562d740e9bfc3601c8385ec1a
Autor:
Robert Lindner, Catherine Sullivan, Onyinye Offor, Kimberly Lezon-Geyda, Kyle Halligan, Neal Fischbach, Mansi Shah, Veerle Bossuyt, Vincent Schulz, David P Tuck, Lyndsay N Harris
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e71915 (2013)
Triple negative breast cancer (TNBC) is characterized by high proliferation, poor differentiation and a poor prognosis due to high rates of recurrence. Despite lower overall incidence African American (AA) patients suffer from higher breast cancer mo
Externí odkaz:
https://doaj.org/article/4a94381861c3475db29ad350e4c60dd9
Autor:
David L. Rimm, Donald R. Lannin, Lajos Pusztai, Veerle Bossuyt, Christian Nixon, Matthew R. Silver, Herbert Haack, Kurt Schalper, Jason R. Brown, Hallie Wimberly
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dab2fc0c1cd1a821ea93a9566419265
https://doi.org/10.1158/2326-6066.22537544.v1
https://doi.org/10.1158/2326-6066.22537544.v1
Autor:
David L. Rimm, Donald R. Lannin, Lajos Pusztai, Veerle Bossuyt, Christian Nixon, Matthew R. Silver, Herbert Haack, Kurt Schalper, Jason R. Brown, Hallie Wimberly
Supplemental Fig 1. Epithelial and stromal PD-L1 expression. Supplemental Fig 2. Validation of specificity of PD-L1 antibody used in this study. Supplemental Fig 3. Correlation with PD-L1 expression and pCR in patient subsets. Supplemental Fig 4. Joi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfefcbd0a1d2aac989a88cb69ddef589
https://doi.org/10.1158/2326-6066.22537541.v1
https://doi.org/10.1158/2326-6066.22537541.v1
Autor:
David L. Rimm, Donald R. Lannin, Lajos Pusztai, Veerle Bossuyt, Christian Nixon, Matthew R. Silver, Herbert Haack, Kurt Schalper, Jason R. Brown, Hallie Wimberly
Supplemental Table 1. Exclusion of Ki67 from Table 4 shows that both stromal and epithelial PD-L1 expressions are highly significant in multivariate analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8291c5cc1eafd529dfff408261c5d85e
https://doi.org/10.1158/2326-6066.22537547.v1
https://doi.org/10.1158/2326-6066.22537547.v1
Autor:
David L. Rimm, Donald R. Lannin, Lajos Pusztai, Veerle Bossuyt, Christian Nixon, Matthew R. Silver, Herbert Haack, Kurt Schalper, Jason R. Brown, Hallie Wimberly
Programmed death 1 ligand 1 (PD-L1) is an immune regulatory molecule that limits antitumor immune activity. Targeting of PD-L1 and other immune checkpoint proteins has shown therapeutic activity in various tumor types. The expression of PD-L1 and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81de45052a546b7554ad2f94025cebc5
https://doi.org/10.1158/2326-6066.c.6548471.v1
https://doi.org/10.1158/2326-6066.c.6548471.v1
Autor:
Veerle Bossuyt, David L. Rimm, Christian Nixon, Donald R. Lannin, Hallie Wimberly, Jason R. Brown
Purpose: Although tumor-infiltrating lymphocytes (TIL) have been associated with response to neoadjuvant therapy, measurement typically is subjective, semiquantitative, and unable to differentiate among subpopulations. Here, we describe a quantitativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aaab08b7c17dbe597c8999bcca31d37
https://doi.org/10.1158/1078-0432.c.6522942
https://doi.org/10.1158/1078-0432.c.6522942
Autor:
Lyndsay N. Harris, William Sikov, Mary Anne Fenton, Maysa M. Abu-Khalaf, George Somlo, Veerle Bossuyt, Eric P. Winer, Ian E. Krop, Amad Awadallah, Shikha Parsai, David Tuck, Kristy L.S. Miskimen, Hannah Gilmore, Vinay Varadan
Supplemental Figure 1. Consort Diagram 03-311. Supplemental Figure 2. Consort Diagram 211B. Supplemental Figure 3. Subtype-specific changes in Immune Index upon brief-exposure to nab-paclitaxel in the 211B trial. Supplemental Figure 4. Evaluation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a5db4057260e4562d3b1ce51541679
https://doi.org/10.1158/1078-0432.22456575.v1
https://doi.org/10.1158/1078-0432.22456575.v1
Autor:
Lyndsay N. Harris, William Sikov, Mary Anne Fenton, Maysa M. Abu-Khalaf, George Somlo, Veerle Bossuyt, Eric P. Winer, Ian E. Krop, Amad Awadallah, Shikha Parsai, David Tuck, Kristy L.S. Miskimen, Hannah Gilmore, Vinay Varadan
Purpose: Recent data suggest that intrinsic subtype and immune cell infiltration may predict response to trastuzumab-based therapy. We studied the interaction between these factors, changes in immune signatures following brief exposure to trastuzumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c37301986569ddb50dbd760168b8c62
https://doi.org/10.1158/1078-0432.c.6523356
https://doi.org/10.1158/1078-0432.c.6523356